Microbiological Testing/Measurement TRIZ Cases

Replacing nucleotide species during polymerase preparation creates clearer nanopore current signals for accurate sequence characterization.

Filler DNA and selective binding capture scarce methylated cfDNA from low-input samples, enabling sensitive sequencing of cancer-specific methylation.

Tumor mutations from solid tissue guide cell-free DNA VAF analysis to estimate circulating tumor fraction despite genomic heterogeneity.

Plasma cfChIP-Seq offers an alternative to invasive biopsy for SCLC subtype classification and disease-load monitoring.

Novel SNP markers identify HPPD-inhibitor-resistant maize early, reducing herbicide phenotyping and breeding generations.

Solid-tumor sequencing identifies patient-specific somatic mutations that guide blood-based VAF measurement for tumor burden and treatment monitoring.

Anti-Gremlin-1 antibodies block GREM1-mediated signaling to address chemoresistant cancers, reduce tumor burden, and prolong survival.

Pyrophosphorolysis and ligation form circular probe constructs for sensitive, multiplex detection with fewer PCR false positives.

A single cg01218619 methylation marker distinguishes T1 from T3/T4 cancer status in non-invasive samples, supporting earlier triage.

A universal master mix and internal controls combine DNA and RNA amplification, reducing PCR handling time and operator errors.

See how non-extendable ssNA anneals to inhibitory DNA regions, limiting renaturation and improving yield across complex templates.

TCEP helps prevent oxidation in nucleotide solutions, supporting room-temperature storage and consistent sequencing without single-use cartridges.

Bridge probes, exonuclease treatment, and adaptor ligation target low-input or damaged DNA while preserving sample complexity.

Primer-flanked barcode controls are amplified in qPCR to reveal cross-contamination and sample swapping during processing.

Methylation-sensitive digestion and dual-probe capture enable one workflow to sequence DNA methylation and mutation states together.

Multimeric reagents append linked barcodes to cell nucleic acids, supporting redundant reads and more accurate sequencing of damaged DNA.

DNA ligase, polymerase, COPs, primers, and dNTPs detect genomic variations from small samples without extra amplification.

Specific amino acid substitutions increase MMLV RTase thermostability and activity for full-length cDNA synthesis from structured RNA.

Primers extend along both sense and antisense strands of a concatemer, avoiding strand removal or resynthesis to reduce sequencing time and errors.

One full-length cDNA library yields RNA 5′-end and gene-body libraries for precise analysis of scarce RNA samples.

Instead of identifying resistance proteins, MALDI-TOF measures β-lactam substrate hydrolysis to classify resistance.

An in vivo PTM rate constant and pharmacokinetic model predict variant serum concentrations and antibody exposure without direct real-time monitoring.

PCR or sequencing of pks island DNA in stool or colonic biopsies helps identify colorectal cancer patients likely to resist anti-PD1 therapy.

Amino acid substitutions stabilize OgLuc variants and coelenterazine reactions for brighter, more reliable bioluminescent assays.

Whole-genome sequencing separates fetal and maternal polymorphisms in unenriched cfDNA for non-invasive prenatal and cancer monitoring.

Computer-designed overhangs help Type IIS enzymes and T4 DNA ligase assemble many DNA fragments in one high-fidelity reaction.

Oligonucleotide-coded probes separate target binding from signal counting, enabling up to 1000 protein or nucleic acid targets in defined tissue regions.

Measure PKA against age- and sex-matched controls to identify ASD phenotype 1 despite heterogeneous patient profiles.

Split initiator probes trigger HCR only after target colocalization, suppressing nonspecific background noise in molecular detection.

Chimeric ligation can create false positives in situ; split barcode region probes filter incorrect products for more specific nucleic acid detection.

Mixed cfDNA signals can obscure individual lesion responses; synthetic fluid hypotheses compare genomic profiles for non-invasive treatment tracking.

Segmented capture probes improve analyte binding and spatial location precision for nucleic acid and protein analysis in tissue.

GWAS and linkage analysis identify Zm00001d012005 to improve maize kernel starch selection and breeding efficiency.

Separate nucleotide flows and match scores improve short-variant calling while reducing reliance on costly high-depth sequencing.

Target Capture Sequences enrich low-abundance tumor DNA before parallel sequencing, improving read depth and reducing whole-genome sequencing needs.

BTKT316A and other BTK mutations reveal ibrutinib resistance, guiding resistance testing and selection of appropriate inhibitors.

Reed-Solomon symbols and layered encoding protect dense nucleic acid data from sequencing errors, lowering the need for costly high-accuracy reads.

Duplex tags distinguish paired and unpaired reads to estimate unseen DNA molecules, improving rare-variant detection and counting accuracy.

A pre-grown bacterial streak creates a defined space for a second sample, exposing diffusible antibiotics missed by conventional screens.

PVT1 promoter-reporter elements convert ecDNA presence into optical signals, simplifying detection in cancer cells.

PLAP-targeted EV-CATCHER purification and miRNA profiling replace invasive assays for earlier placental pathology detection.

Specific circulating RNA signatures address weak protein-biomarker discrimination for earlier preeclampsia detection and risk assessment.

Current tools struggle to separate patients needing immediate therapy from those suited to surveillance; a 12-gene GPS score refines that decision.

Low-throughput microscopy makes single-cell marker relationships difficult to automate; paired RCA identifiers enable sequencing-based cell-polarity maps.

Temperature-dependent DNA aptamer binding inhibits unwanted reverse transcriptase activity and enables controlled release for cDNA synthesis.

A five-marker PCR panel detects CMMRD MSI in blood and other samples without high-capacity sequencing.

Separate EPIS and TMES gene scores distinguish tumor epithelium from its microenvironment to predict CRC therapy response and survival.

Species-specific methylation arrays profile small DNA samples from animal-derived products for faster, robust origin, welfare, and health assessment.

Conventional cancer detection can be confounded by irrelevant genomic information; phased cell-free DNA reads isolate parental haplotype signatures for higher predictive accuracy.

Probe barcodes mark analyte proximity through ligation and amplification for high-resolution tissue analysis.

SNP markers identify resistance alleles to accelerate breeding and reduce nematode damage.

A flow cytometry panel detects minimal residual disease in acute lymphoblastic leukemia using specific surface markers.

Dynamic hydrophilic patches on a substrate enable precise nucleic acid positioning while maintaining droplet mobility for efficient sequencing.

Laser-induced fluorescence detection in capillary electrophoresis analyzes RNA genome integrity, reducing analysis time and variability compared to RT-PCR.

Compartmentalized volumes with encoded particles isolate reactions to eliminate cross-talk, enabling absolute quantification without calibration curves.

Parallel oligonucleotide arrays enable sequence verification to reduce synthesis errors and costs for high-quality variant libraries.

A biosensor chip uses centrifugal force to dispense specimens into quantification chambers positioned away from the rotational center.

A phenol-based extraction solution utilizes high-density halo-substituted alkyl compounds to achieve automatic phase separation without centrifugation.

Inflammasome biomarker measurement determines absorbed radiation dose rapidly, bypassing slow clinical symptom monitoring delays.

Novel maize inbred PH2F3P integrates specific stress resistance traits into a high-yield genetic background for commercial crop production.

Single-cell RNA sequencing profiles malignant plasma cells to overcome proteasome inhibitor resistance and enable tailored treatment strategies.

Mapping novel quantitative trait loci enables marker-assisted selection of resistant soybeans, reducing reliance on chemical nematocides.

Segmenting cells into droplets with universal beads preserves individual epigenetic methylation data while reducing required sample quantity.

A solid agar composition integrates luciferase and D-luciferin to detect ATP from intact bacterial cultures.

XB05Y12 soybean achieves stable disease resistance and yield by segmenting complex breeding timelines into focused parental trait combinations.

Disulfide-linked beads release barcodes via reduction to enable parallel genomic sequencing.

Methanol-responsive polymer tags enable selective precipitation of single-stranded DNA during PCR amplification.

Segmenting complex genetic data into specific SLC45A2 and MC1R markers resolves the trade-off between diagnostic accuracy and testing complexity.

USER-mediated self-looping combined with rolling circle replication increases yield from micrograms to nanomoles while maintaining sequence fidelity.

Replacing invasive biopsies, RNA in situ hybridization analyzes urine mRNA expression levels to distinguish high-risk from low-risk prostate cancers.

Type IIS restriction enzymes cleave polynucleotides to enrich miRNA populations, bypassing time-consuming gel electrophoresis.

Segmented TSU primers minimize multiplex interactions to enhance sensitivity and simplify assay design for rapid pathogen detection.

Segmented in vitro assay detects oncogenic potential via differentiation-blocked progenitor cells, resolving insufficient lymphoid leukemia risk identification.

Quaternary ammonium compounds stabilize fragile RNA at room temperature, eliminating complex purification and enabling rapid point-of-care diagnostics.

Quantifying circulating SCN5A protein levels in bodily fluids provides a non-invasive diagnostic method for pulmonary hypertension.

Nucleic acid nanoparticles generate unique electrical signatures during nanopore transit to detect multiple biomarkers simultaneously.

Unique molecular tags identify individual nucleic acid templates before amplification.

Active magnetic mixing prevents long polynucleotide damage during extraction, enabling accurate sequencing of epigenetic modifications.

Administering a teneurin modulator inhibits teneurin-4 expression to treat astrocytoma, glioblastoma, and oligodendroglioma.

Two-domain nucleic acid probes use non-nucleoside linkers to drive hybridization without stem-loop formation.

Synthetic biological circuits translate diverse analytes into glucose signals, allowing universal detection via standard glucometers without device complexity.

A photoelectric conversion element incorporates an electron blocking layer with a specific surface potential change to prevent charge leakage between adjacent pixels.

Methylation status of CCR6 and BLR1 genes differentiates stable from transient T cell activation for autoimmune disease diagnosis.

PCR assays with O-grp-2 and H-ag primers detect Salmonella serotypes, replacing slow traditional methods to cut identification time from days to hours.

Diagnostic kits measure mitochondrial markers to guide therapy, reducing tumor recurrence and resistant clones.

RAD21, HER2, and PDL1 biomarkers predict pathologic complete response rates to guide personalized therapy.

Automated optical analyzer detects intrinsic bacterial fluorescence to differentiate strains without external labels.

CD11b marker segmentation identifies myeloid NK-cell subsets for targeted metabolic therapy.

A gene sequencing structure uses a thin-film transistor array to detect ionic current changes during nucleic acid base pairing.

Analyzing specific DNA methylation markers via bisulfite treatment and PCR resolves the trade-off between diagnostic sensitivity and procedural invasiveness.

A lysine decarboxylase mutant with enhanced thermal stability catalyzes 1,5-pentadiamine synthesis from L-lysine.

Proteomic analysis identifies salivary biomarkers to detect oral squamous cell carcinoma, resolving the lack of reliable non-invasive diagnostic tools.

Enzymatic elongation cycles coupled with intermediate purification retain correct sequences while removing errors during synthesis.

Molecular combing stretches viral genomes for sequence-specific probe hybridization to identify infectious particles.

RNase T1 segmentation isolates polyadenylated mRNA regions, resolving low-resolution and high-sample bottlenecks in GMP quality control.

A targeting vector uses nuclear localization signals and bait peptides to recruit RAD51 machinery for precise gene integration.

Measuring host cell protein expression levels predicts disulfide bond reduction risk in monoclonal antibody production.